A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AWARE / Assessing Worldwide Antimicrobial Resistance Evaluation

[Related PubMed/MEDLINE]
Total Number of Papers: 13
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AWARE  (>> Co-occurring Abbreviation)
Long Form:   Assessing Worldwide Antimicrobial Resistance Evaluation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Activity of ceftaroline against pathogens associated with community-acquired pneumonia collected as part of the AWARE surveillance program, 2015-2016. ---
2016 In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014. MRSA, MSSA
2015 Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America - results of AWARE surveillance 2012. ESBLs, SSTIs
2015 In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme. SSTIs
2015 In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program. MRSA, PBP2a, ST5
2015 Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998. MRSA, PBP2A, ST228
2014 Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among beta-lactam agents. ---
2013 Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010). cSSTIs, MRSA, MSSA, VGS
2012 Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program. MRSA, MSSA
10  2012 AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. ---
11  2012 Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program. CoNS, MIC, MRSA
12  2012 Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010). CARTI, CLSI
13  2012 Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program. CoNS, MRSA